260 related articles for article (PubMed ID: 25297940)
1. Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions.
Briley-Saebo K; Yeang C; Witztum JL; Tsimikas S
J Cardiovasc Transl Res; 2014 Nov; 7(8):719-36. PubMed ID: 25297940
[TBL] [Abstract][Full Text] [Related]
2. Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics.
Miller YI; Tsimikas S
Curr Opin Lipidol; 2013 Oct; 24(5):426-37. PubMed ID: 23995232
[TBL] [Abstract][Full Text] [Related]
3. Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes.
Briley-Saebo KC; Cho YS; Shaw PX; Ryu SK; Mani V; Dickson S; Izadmehr E; Green S; Fayad ZA; Tsimikas S
J Am Coll Cardiol; 2011 Jan; 57(3):337-47. PubMed ID: 21106318
[TBL] [Abstract][Full Text] [Related]
4. Imaging of Oxidation-Specific Epitopes in Atherosclerosis and Macrophage-Rich Vulnerable Plaques.
Briley-Saebo KC; Cho YS; Tsimikas S
Curr Cardiovasc Imaging Rep; 2011 Feb; 4(1):4-16. PubMed ID: 21297859
[TBL] [Abstract][Full Text] [Related]
5. Manganese G8 dendrimers targeted to oxidation-specific epitopes: in vivo MR imaging of atherosclerosis.
Nguyen TH; Bryant H; Shapsa A; Street H; Mani V; Fayad ZA; Frank JA; Tsimikas S; Briley-Saebo KC
J Magn Reson Imaging; 2015 Mar; 41(3):797-805. PubMed ID: 24610640
[TBL] [Abstract][Full Text] [Related]
6. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.
Briley-Saebo KC; Shaw PX; Mulder WJ; Choi SH; Vucic E; Aguinaldo JG; Witztum JL; Fuster V; Tsimikas S; Fayad ZA
Circulation; 2008 Jun; 117(25):3206-15. PubMed ID: 18541740
[TBL] [Abstract][Full Text] [Related]
7. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's.
den Adel B; Bovens SM; te Boekhorst B; Strijkers GJ; Poelmann RE; van der Weerd L; Pasterkamp G
Atherosclerosis; 2012 Dec; 225(2):274-80. PubMed ID: 22882907
[TBL] [Abstract][Full Text] [Related]
8. In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes.
Briley-Saebo KC; Nguyen TH; Saeboe AM; Cho YS; Ryu SK; Volkova ER; Dickson S; Leibundgut G; Wiesner P; Green S; Casanada F; Miller YI; Shaw W; Witztum JL; Fayad ZA; Tsimikas S
J Am Coll Cardiol; 2012 Feb; 59(6):616-26. PubMed ID: 22300697
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions.
van Dijk RA; Kolodgie F; Ravandi A; Leibundgut G; Hu PP; Prasad A; Mahmud E; Dennis E; Curtiss LK; Witztum JL; Wasserman BA; Otsuka F; Virmani R; Tsimikas S
J Lipid Res; 2012 Dec; 53(12):2773-90. PubMed ID: 22969153
[TBL] [Abstract][Full Text] [Related]
10. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
11. Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis.
Leibundgut G; Witztum JL; Tsimikas S
Curr Opin Pharmacol; 2013 Apr; 13(2):168-79. PubMed ID: 23541680
[TBL] [Abstract][Full Text] [Related]
12. Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression.
Chen W; Cormode DP; Vengrenyuk Y; Herranz B; Feig JE; Klink A; Mulder WJ; Fisher EA; Fayad ZA
JACC Cardiovasc Imaging; 2013 Mar; 6(3):373-84. PubMed ID: 23433925
[TBL] [Abstract][Full Text] [Related]
13. Oxidation-specific epitopes are major targets of innate immunity in atherothrombosis.
Bartolini Gritti B; Binder CJ
Hamostaseologie; 2016 May; 36(2):89-96. PubMed ID: 25682990
[TBL] [Abstract][Full Text] [Related]
14. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.
Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization.
Wagner S; Schnorr J; Ludwig A; Stangl V; Ebert M; Hamm B; Taupitz M
Int J Nanomedicine; 2013; 8():767-79. PubMed ID: 23450179
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.
Shen ZT; Zheng S; Gounis MJ; Sigalov AB
PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115
[TBL] [Abstract][Full Text] [Related]
17. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.
Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y
Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623
[TBL] [Abstract][Full Text] [Related]
18. PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.
Senders ML; Que X; Cho YS; Yeang C; Groenen H; Fay F; Calcagno C; Meerwaldt AE; Green S; Miu P; Lobatto ME; Reiner T; Fayad ZA; Witztum JL; Mulder WJM; Pérez-Medina C; Tsimikas S
J Am Coll Cardiol; 2018 Jan; 71(3):321-335. PubMed ID: 29348025
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.
Yu M; Ortega CA; Si K; Molinaro R; Schoen FJ; Leitao RFC; Xu X; Mahmoudi M; Ahn S; Liu J; Saw PE; Lee IH; Brayner MMB; Lotfi A; Shi J; Libby P; Jon S; Farokhzad OC
Theranostics; 2018; 8(21):6008-6024. PubMed ID: 30613278
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive Molecular Imaging of Mouse Atherosclerosis.
McAteer MA; Choudhury RP
Methods Mol Biol; 2015; 1339():61-83. PubMed ID: 26445781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
